Securities Fraud Lawsuit Alerts Issued for Aardvark Therapeutics and Primoris Services

Shareholders of Aardvark Therapeutics and Primoris Services have been notified of ongoing securities fraud class actions that may entitle them to seek lead plaintiff status. The alerts outline key deadlines and eligibility criteria for investors who experienced financial losses following alleged corporate misconduct.